Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Metolazone is a thiazide-like diuretic (water pill) used to treat fluid retention (edema) and swelling caused by congestive heart failure, kidney disease (such as nephrotic syndrome), or other medical conditions. It is also prescribed alone or in combination with other medications to manage high blood pressure (hypertension). Metolazone works primarily by inhibiting sodium reabsorption at the cortical diluting site of the renal tubule and, to a lesser extent, in the proximal convoluted tubule. This leads to increased excretion of sodium and chloride ions, resulting in diuresis and reduced blood pressure. The antihypertensive effect is presumed to be related to its saluretic and diuretic properties[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on metolazone.